[go: up one dir, main page]

PA8842701A1 - Granulado que contiene nicotina - Google Patents

Granulado que contiene nicotina

Info

Publication number
PA8842701A1
PA8842701A1 PA20098842701A PA8842701A PA8842701A1 PA 8842701 A1 PA8842701 A1 PA 8842701A1 PA 20098842701 A PA20098842701 A PA 20098842701A PA 8842701 A PA8842701 A PA 8842701A PA 8842701 A1 PA8842701 A1 PA 8842701A1
Authority
PA
Panama
Prior art keywords
nicotine
granulate containing
containing nicotine
granulate
powder
Prior art date
Application number
PA20098842701A
Other languages
English (en)
Inventor
Tillmann Roerich
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Publication of PA8842701A1 publication Critical patent/PA8842701A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN GRANULADO QUE CONTIENE NICOTINA,REDUCIDO EN POLVO,QUE COMPRENDE UNA MEZCLA HOMOGÉNEA DE NICOTINA O UN DERIVADO DE NICOTINA FARMACÉUTICAMENTE ACEPTABLE Y UN EXCIPIENTE.EL GRANULADO TIENE UN TAMAÑO DE PARTÍCULA DE AL MENOS 150µM.MÉTODO PARA LA PREPARACIÓN DE UN GRANULADO QUE CONTIENE NICOTINA,REDUCIDO EN POLVO Y EL USO DEL GRANULADO QUE CONTIENE NICOTINA PARA LA PREPARACIÓN DE PRODUCTOS FARMACÉUTICOS.
PA20098842701A 2008-09-17 2009-09-17 Granulado que contiene nicotina PA8842701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08016336A EP2177213B1 (en) 2008-09-17 2008-09-17 Nicotine-containing granulate

Publications (1)

Publication Number Publication Date
PA8842701A1 true PA8842701A1 (es) 2010-04-21

Family

ID=40091848

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20098842701A PA8842701A1 (es) 2008-09-17 2009-09-17 Granulado que contiene nicotina

Country Status (17)

Country Link
US (1) US10413512B2 (es)
EP (1) EP2177213B1 (es)
AR (1) AR073604A1 (es)
AU (1) AU2009294964B2 (es)
CA (1) CA2734402C (es)
DK (1) DK2177213T3 (es)
ES (1) ES2401912T3 (es)
HR (1) HRP20130161T1 (es)
MX (1) MX2011002696A (es)
NZ (1) NZ591198A (es)
PA (1) PA8842701A1 (es)
PL (1) PL2177213T3 (es)
PT (1) PT2177213E (es)
SI (1) SI2177213T1 (es)
UY (1) UY32127A (es)
WO (1) WO2010031536A1 (es)
ZA (1) ZA201101123B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2198865E (pt) * 2008-12-19 2012-02-07 Siegfried Ltd Produto que contém nicotina
EP2964261A4 (en) * 2013-03-07 2016-07-27 Amneal Pharmaceuticals Llc STABILIZATION OF MOISTURE-SENSITIVE DRUGS
ES2842585T3 (es) * 2013-10-03 2021-07-14 Altria Client Services Llc Pastilla para chupar
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US10105320B2 (en) * 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US12274276B2 (en) 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
AU2016321659A1 (en) * 2015-09-14 2018-05-10 Merck Patent Gmbh Formulation having controlled, delayed active-ingredient release
US11311623B2 (en) 2016-04-21 2022-04-26 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S Nicotine pouch
JP7278281B2 (ja) 2017-12-08 2023-05-19 フェルティン ファルマ アー／エス ニコチン錠
EP3720497A1 (en) 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine concentration
BR112020011238A2 (pt) * 2017-12-08 2021-01-05 Fertin Pharma A/S Formulação de nicotina oral sólida para alívio de desejo de nicotina de início rápido, formulação de nicotina oral sólida para uso na atenuação do desejo de nicotina, método de atenuação do desejo de nicotina e bolsa oral
EP3993646B1 (en) 2019-07-05 2023-08-16 Swedish Match North Europe AB An oral pouched nicotine product including a filling material comprising nicotine-containing particles
CN120919066A (zh) * 2019-08-30 2025-11-11 伊维股份有限公司 装载的颗粒、其生产方法及其用途
HUE066565T2 (hu) 2019-11-20 2024-08-28 Swedish Match North Europe Ab Orálisan alkalmazható tasakos nikotintermék, beleértve egy nikotinrészecskéket tartalmazó töltõanyagot
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US20220304366A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Oral products with reduced irritation
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US20220313614A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Encapsulated nicotine granules and methods of preparation thereof
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
MX2023015529A (es) 2021-06-25 2024-03-05 Nicoventures Trading Ltd Productos orales y metodo de fabricacion.
CN114304712A (zh) * 2021-12-17 2022-04-12 深圳市元雾科技有限公司 一种液体高负载的尼古丁口含制品颗粒及其制备方法
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104787B (fi) 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
SE8904295D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6276917B1 (en) * 1999-01-28 2001-08-21 Botanicals International Powder processing apparatus
FR2792200B3 (fr) * 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
DE19943496C1 (de) 1999-09-10 2001-05-17 Suedzucker Ag Direkt verpressbarer Rohstoff für Komprimate
WO2002076605A1 (de) 2001-03-23 2002-10-03 Symrise Gmbh & Co. Kg Verfahren zur herstellung von einkapselungen
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
WO2008012071A2 (en) 2006-07-24 2008-01-31 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof

Also Published As

Publication number Publication date
NZ591198A (en) 2012-03-30
EP2177213A1 (en) 2010-04-21
AU2009294964A1 (en) 2010-03-25
US20110165253A1 (en) 2011-07-07
DK2177213T3 (da) 2013-02-11
US10413512B2 (en) 2019-09-17
CA2734402A1 (en) 2010-03-25
HRP20130161T1 (hr) 2013-03-31
AU2009294964B2 (en) 2012-12-13
WO2010031536A1 (en) 2010-03-25
CA2734402C (en) 2013-05-14
PT2177213E (pt) 2013-02-21
SI2177213T1 (sl) 2013-03-29
MX2011002696A (es) 2011-04-05
AR073604A1 (es) 2010-11-17
PL2177213T3 (pl) 2013-08-30
ZA201101123B (en) 2012-04-25
EP2177213B1 (en) 2013-01-02
ES2401912T3 (es) 2013-04-25
UY32127A (es) 2010-04-30

Similar Documents

Publication Publication Date Title
PA8842701A1 (es) Granulado que contiene nicotina
PA8815501A1 (es) Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa
MX2009010289A (es) Composiciones para administracion nasal.
CO6400186A2 (es) Tabletas de acetato de ulipristal
AR089578A1 (es) Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
AR059358A1 (es) Formulaciones farmaceuticas
CL2007003685A1 (es) Compuestos derivados de indol con un anillo unido en las posiciones 4 y 5; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion viral.
CL2007003684A1 (es) Compuestos derivados de indol con un anillo unido en las posiciones 5 y 6; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion viral.
SV2016005236A (es) Formulación compuesta para administración oral que comprende ezetimibe y rosuvastatina
CO2017013293A2 (es) Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina
CR20120218A (es) Composición farmacéutica que comprende un agonista de glp-1, una insulina y metionina
UY32252A (es) Composicion farmaceutica de un potente inhibidor de hcv para su administracion oral
CR9339A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
AR091233A1 (es) Composicion farmaceutica que comprende abediterol
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
CY1114933T1 (el) Στερεες φαρμακευτικες συνθεσεις σταθερης δοσης περιεχουσες ιρβεσαρτανη και αμλοδιπινη, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
UA105285C2 (uk) Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання
MX375187B (es) Composiciones farmacéuticas secas que comprenden nanopartículas de agente activo ligadas a partículas portadoras.
AR113885A1 (es) Formulaciones de péptidos de liberación sostenida
CL2011002651A1 (es) Composicion veterinaria que comprende dipropionato de imidocarb, cianocobalamina vitamina b12 y un vehiculo farmaceuticamente aceptable; y su uso para tratar o prevenir enfermedades infecciosas parasitarias en ganado.
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
CL2016000183A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación